Edit |   |
---|---|
Antigenic Specificity | CD40LG, Human (Ruplizumab biosimilar) |
Clone | Ruplizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | IF, IP, Neut, FuncS, ELISA, FCM |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD40LG Recombinant Antibody. Ruplizumab (trade name Antova) is a humanized monoclonal antibody intended for the treatment of rheumatic diseases like systemic lupus erythematosus and lupus nephritis. A study showed that the drug was associated with life-threatening thromboembolisms, while another study only found thrombocytopenia. |
Immunogen | n/a |
Other Names | Anti-CD40LG Recombinant Antibody, Research Grade Ruplizumab, Anti-Human CD40LG Recombinant Antibody, BG-9588, hu5c8, Ruplizumab, Antibody Drug Analogues, Monoclonal Antibody, YR1017, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 220651-94-5 |
Catalog # | YR1017 |
Price | please inquire |
Order / More Info | CD40LG, Human (Ruplizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |